✦ LIBER ✦

Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia

✍ Scribed by Paul A. Bartley; Michael H. Martin-Harris; Bradley J. Budgen; David M. Ross; Alexander A. Morley

Book ID: 108676669
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 150 KB
Volume: 149
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.08071.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of FLT3 mutations and promyelocyt

Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia

✍ Florian Kuchenbauer; Claudia Schoch; Wolfgang Kern; Wolfgang Hiddemann; Torsten 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Requirement for myeloid growth factors i

Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia

✍ William Matsui; B. Douglas Smith; Milada Vala; Nikeshia Beal; Carol Ann Huff; Lo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Cloning and characterization of the T(15

Cloning and characterization of the T(15;17) translocation breakpoint region in acute promyelocytic leukemia

✍ Dr. Richard S. Lemons; David Eilender; Richard A. Waldmann; Matt Rebentisch; Ann 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

A reciprocal chromosomal translocation, t( I 5; I7)(q22;q I I .2-I2), is characteristic of acute promyelocytic leukemia (APL) of French-American-British (FAB) subtype M3, and is not associated with any other human malignancy. The non-random pattern of the APL translocations suggests that specific ge

Low expression of the putative tumour su

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia

✍ Jacqueline Boultwood; Andrea Pellagatti; Fiona Watkins; Lisa J. Campbell; Noor E 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Oral idarubicin in the treatment of acut

Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia

✍ S. T. A. Malik; J. Tucker; A. Z. S. Rohatiner; W. Brace; T. A. Lister 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per

Subiocalization of the chromosome 5 brea

Subiocalization of the chromosome 5 breakpoint of the 3;5 translocation in myelodysplastic syndromes and acute myeloid leukemia

✍ Dr. Stephan W. Morris; John T. Foust; Marcus B. Valentine; W. Mark Roberts; Davi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

A t(3;5)(q25. I ;q34) reciprocal translocation identifies a subset of cases of myelodysplastic syndrome o r acute myeloid leukemia (AML) that are characterized by increased numbers of megakaryocytes and severe trilineage dysplasia. As a first step in characterizing the t(3;5) breakpoints, we asked w